Navigation Links
Oxford BioTherapeutics Licenses BioWa's POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer
Date:4/6/2011

PRINCETON, N.J., and OXFORD, England, April 6, 2011 /PRNewswire/ -- BioWa, Inc. (BioWa) and Oxford BioTherapeutics Ltd (OBT) today announced that they have entered into a license agreement to provide OBT with access to BioWa's patented POTELLIGENT® Technology platform for the development of antibody dependent cellular cytotoxicity (ADCC) enhanced antibodies.  

OBT intends to use POTELLIGENT® Technology to develop, manufacture and commercialize selected ADCC programs from its pipeline of preclinical antibodies for oncology which it has built based upon novel targets identified using its OGAP® proteomic database.

In return for the license, OBT will pay to BioWa undisclosed license fees, development and commercialization milestones and royalties on sales of any products that it commercializes.

"We are delighted to have access to BioWa's POTELLIGENT® Technology as part of our technology access portfolio as we build a pipeline of first-in-class therapeutic antibodies for cancer," said Christian Rohlff, CEO of OBT.  "Our strategy is to combine novel proprietary oncology targets with world-leading antibody technologies, such as POTELLIGENT® Technology, to develop highly efficacious new cancer drugs for patients with few treatment options."  

"The OBT cancer specific antibody portfolio has matured to an advanced stage where coupling to BioWa's POTELLIGENT® Technology enhances already promising anticancer agents and further enables our clinical development pipeline," commented OBT's Senior Vice President of Oncology, Jon Terrett.

"We are excited to expand our set of small company arrangements with OBT. In large part, our decision to partner with OBT was driven by our interest in novel therapeutic antibody targets identified through the OGAP® proteomic database," said Yasunori Yamaguchi, President and CEO of BioWa.

About POTELLIGENT® Technology

POTELLIGENT®
'/>"/>

SOURCE BioWa, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ICAP Ocean Tomo Announces Four Patent Sets From Oxford Instruments - Each Represents an Important Advancement in Technology
2. Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation
3. Oxford Finance Corporation Hires Debbie Baker to Support Life Science Business Development in Western North America
4. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
5. Oxford Finance Corporation and United Orthopedic Group, Inc. Close $20 Million Credit Facility
6. Oxford Finance Corporation Facilitates Entry for Reata Pharmaceuticals into Asian Markets
7. Oxford Finance Corporation Closes $25 Million Credit Facility with EUSA Pharma
8. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
9. CardioVascular BioTherapeutics Submits FDA Application for Fast Track Status for CVBT-141B, CVBTs Biological Treatment for Diabetes Patients
10. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
11. Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 ... report is available in its catalogue: ... 2014-2024 http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... – discover technological and commercial prospects What ... delivery market? Visiongain,s brand new report shows ...
(Date:8/28/2014)... Pharmatech initiated enrollment for its AccessPPM ... method for matching cancer patients to cancer clinical ... specific cancers, disease staging, and genetic mutations - ... in the first place. The challenge that the ... be well known to the patient or even ...
(Date:8/28/2014)... 2014 Tianyin Pharmaceutical Co., Inc. (NYSE ... that specializes in patented biopharmaceutical, modernized traditional Chinese ... (API) today updates the timeline for the GMP ... The Company is scheduled to submit ... Food & Drug Administration,s (CFDA) review in the ...
Breaking Medicine Technology:Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches 2TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2
... The High Court of Germany ( Bundesgerichtshof ) handed ... in its dispute with the Finnish company Medix Biochemica. The ... associated with Medix,s ActimPROM test is null and void due ... to pay AmniSure® an undisclosed amount to be determined by ...
... -- Chindex International, Inc. ("Chindex") (Nasdaq: CHDX ... products and services in the People,s Republic of China, ... results for the three and nine-month periods ended December ... market closes. Management will host a conference call at ...
Cached Medicine Technology:German High Court Rules in Favor of AmniSure® as New European Guidelines Published 2Chindex International to Report Financial Results for the Three and Nine-Month Periods Ended December 31, 2010 2
(Date:8/29/2014)... Food and Drug Administration (FDA)-approved treatment for decreasing ... effective at reducing fracture risk as other current ... loss. With the use of wide- and small-angle ... out experiments at the U.S. Department of Energy,s ... Laboratory that revealed an additional mechanism underlying raloxifene ...
(Date:8/29/2014)... Francisco, CA (PRWEB) August 30, 2014 ... 10 best web conference providers in the online service ... the list were global leaders Webex, GotoMeeting and Infinite. ... the industry users have to determine which provider is ... Essentially, web conference businesses search for compelling consumer goods ...
(Date:8/29/2014)... 2014 The 8th Annual Paint Columbus Pink® ... a Cause, Pink Pooch Contest, Light of Life Ceremony, Power ... Pink Bow Campaign – all in support of cancer awareness. ... this year…. Paint Columbus Pink Foam and Obstacle Challenge on ... 727 54th Street, Columbus, Georgia 31904. It will be the ...
(Date:8/29/2014)... 29, 2014 After having a double ... had to have breast reconstruction. She found that the ... she decided that there needed to be a solution. ... a woman or man who needs or wants breast ... promotes confidence and peace of mind. Producible in design ...
(Date:8/29/2014)... 2014 University of Western States (UWS), ... announced that Daniel Redwood, DC, director of the human ... the Year,” by the Missouri State Chiropractors Association (MSCA) ... , Patrick Montgomery, DC, president of the MSCA, cited ... Missouri House Task Force for Medicaid Reform, in bringing ...
Breaking Medicine News(10 mins):Health News:Revealing a novel mode of action for an osteoporosis drug 2Health News:Top10InAction Reveals Best Web Conference Providers 2Health News:Paint Columbus Pink Cancer Awareness/Kick-Off Meeting for Anyone Interested in Participating 2Health News:University of Western States Director of Human Nutrition and Functional Medicine Daniel Redwood, DC, named Missouri Educator of the Year by MSCA 2
... June 03, 2010 The John Theurer Cancer Center ... physicians and researchers will present 16 abstracts on treatment ... during the Annual Meeting of American Society of Clinical ... "At the John Theurer Cancer Center, we,re ...
... Americans now have choices ... treatment in the USA, Medical Tourism is the answer. , ... Carlsbad, CA (PRWEB) June 2, 2010 – Website promotes the healthcare options ... USA. , , ,Global Medical Connect is a one stop medical tourism shop to take care ...
... , THURSDAY, June 3 (HealthDay News) -- Fatal medication ... of the inexperience of new medical residents, a new ... July, and those first weeks may be a dangerous ... the University of California, San Diego. , The ...
... say it,s not always that simple, , THURSDAY, June 3 ... in many a parent. But having to incorporate information ... make an already sensitive subject even more complicated. , Yet ... As assisted reproduction technology, in which someone other than the ...
... ... Lake Host Malaria Awareness Soccer Clinic this Thursday for Local Youth as part of White ... ... the United Nations Foundation ’s Nothing But Nets campaign are teaming up to raise ...
... ... research study that provides detailed analyses on health plans’ coverage and management of ... ... Pharmaceuticals Service is an ongoing market research study that provides detailed analyses on ...
Cached Medicine News:Health News:Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO 2Health News:Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO 3Health News:Global Medical Connect Launches New Website for the Growing Medical Tourism Industry 2Health News:Donor-Assisted Conception Sparks Disclosure Dilemmas 2Health News:Donor-Assisted Conception Sparks Disclosure Dilemmas 3Health News:Real Salt Lake Teams Up with Nothing But Nets to Fight Malaria 2Health News:Real Salt Lake Teams Up with Nothing But Nets to Fight Malaria 3Health News:HIRC Research Alert: Health Plans Expected to Increase Adoption of Percent Copays to Manage Specialty Medications 2Health News:HIRC Research Alert: Health Plans Expected to Increase Adoption of Percent Copays to Manage Specialty Medications 3
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
... MicroDigital IP 6.2 Series Image Processing Video ... for all surgical specialties. This camera incorporates ... such as brightness, enhancement, gain, and white ... Multiple-range image enhancement and adjustable picture level ...
... Halogen Light Source is similar ... addition of dual lamps and ... light source is ideal for ... the added feature of a ...
Medicine Products: